RAHBAR
RAHBAR MBBSMedicine & Allied • Third Year Deep Learning Master
 ← Year 03 Subjects
YEAR 03 • MEDICINE & ALLIED • 20-MODULE • FULL CHAPTER MASTER

Medicine & Allied Learning Material

20 learning units covering clinical assessment, common medical presentations, urgent warning signs and allied specialties. Read the chapters, revise the key distinctions, then attempt 10 explained questions per unit in practice or assessment mode.

Academic scope: Original RAHBAR notes for the Year 3 clinical transition, informed by PM&DC medicine and allied domains. Institutional sequencing may differ. Examples are educational; clinical decisions and procedures require appropriate supervision and current local protocols. Sources & further reading ↓
MA
● MODULE 14 / 20

Anemia, Bleeding & Medical Oncology

Interpret blood-count patterns, recognize hematological emergencies and understand the foundations of cancer care.

Quick revision ↓ Medical Dictionary

FULL CHAPTER EXPLANATION

Deep Learning — Module 14

Connect symptoms and examination findings to a differential, targeted investigations, initial priorities and reassessment.

01

Anemia as a finding

Anemia is reduced hemoglobin relative to the appropriate reference context and is not a final diagnosis. Assess symptoms, rate of change, bleeding, diet, medicines, chronic disease and family history. Mean cell volume organizes a differential but does not prove etiology. Reticulocyte response helps distinguish reduced production from loss or destruction, while a blood film can reveal additional clues. Severe symptoms or instability determine urgency alongside the hemoglobin value.

02

Iron, vitamins and hemolysis

Iron deficiency requires a search for cause, including blood loss where relevant, rather than replacement alone. Ferritin can rise with inflammation and may conceal deficiency. Macrocytosis can arise from vitamin deficiency, liver disease, drugs or marrow conditions; a normal cell size does not exclude every mixed deficiency. Hemolysis may cause reticulocytosis, bilirubin elevation and other laboratory changes. Interpret the pattern and clinical context rather than one marker alone.

03

Bleeding and coagulation

Platelet disorders often cause mucosal bleeding or petechiae, while coagulation-factor disorders may cause deep bleeding, but overlap occurs. Review anticoagulants, liver disease, infection and inherited history. Coagulation tests do not detect every bleeding disorder and their interpretation depends on medicines and sampling. Significant bleeding requires immediate physiological assessment and appropriate support. Transfusion decisions balance symptoms, ongoing loss, comorbidity and protocol, with identity checks and monitoring for reactions.

04

Marrow and malignant disease

Unexplained cytopenias, abnormal cells, persistent lymphadenopathy, weight loss or systemic symptoms may require hematological investigation. Diagnosis of malignancy generally integrates tissue or cellular characterization with staging and functional assessment. Grade and stage answer different questions. Treatment can include systemic therapy, radiotherapy, surgery and supportive care according to disease and patient priorities. Communicate uncertainty clearly and avoid declaring cancer from a nonspecific isolated laboratory abnormality.

05

Oncological emergencies

Fever or severe illness in a patient at risk of neutropenia needs urgent assessment and treatment through the relevant pathway. Cancer can also cause spinal-cord compression, hypercalcemia, thrombosis or tumor lysis with dangerous electrolyte and renal effects. Recognize these syndromes without waiting for every diagnostic detail. Palliative care addresses symptoms and quality of life alongside disease-directed treatment and is not restricted to the final hours of life.

High-Yield Revision

  • Anemia needs a cause, not just a replacement prescription.
  • Ferritin can be influenced by inflammation.
  • Possible neutropenic sepsis is time critical.

Common Exam & Concept Pitfalls

  • Do not diagnose cancer from a nonspecific result alone.
  • Do not equate palliative care with abandonment of treatment.

Sources & Further Reading

Curriculum and reference review: 24 September 2026. These original notes teach clinical reasoning and recognition, not standalone prescribing or procedure protocols. International guidance supports the principles below; local pathways, resources and authorized supervision govern patient care. Faculty review is pending.

RAHBAR study structure: presentation → examination → differential → investigation → care priorities → reassessment. Use institutional curriculum and faculty guidance for supervised clinical skills and assessment requirements.